<p>Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.</p>

Following the May 3 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss the FDA’s memorandum of understanding (MOU) for compounding pharmacies distributing medications interstate, the REMS comment period for opioid analgesics, new BOP security rules and more.

Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes

IPA’s What, Why & How podcast unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Board of Pharmacy. Each month, IPA’s CEO, Kate Gainer, welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice.

Medicine

Health & Fitness

IPA’s What, Why &amp; How podcast unravels the intricacies of pharmacy and healthcare law and regulation, from Congress to the Board of Pharmacy. Each month, IPA’s CEO, Kate Gainer, welcomes a special guest to explore WHAT changes occurred, WHY action was taken, and HOW these changes will impact pharmacy practice.

Share Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes

Sign up to save your podcasts

Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes

Episode #38: May 2022 – Compounding Pharmacies, Comment Periods & Security Changes